HF
ORGS

HRT Financial’s Orgenesis Inc. Common Stock ORGS Stock Holding History

HRT Financial’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,258
Closed -$260K – 4272
2021
Q3 		$260K Sell
5,258
-275
-5% -$13.8K ﹤0.01% 2509
2021
Q2 		$280K Buy
+5,533
New +$279K ﹤0.01% 2189

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HRT Financial's ORGS Position: Q4 2021 in Review

HRT Financial sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2021, closing a stake of 5,258 shares — an estimated $260K sold.

HRT Financial first reported a position in ORGS in Q2 2021 and held it in 2 quarters. The position peaked at $280K in Q2 2021. 26 funds tracked by Wall St. Rank hold ORGS as of Q4 2021.

  • HRT Financial reported no remaining Orgenesis Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 5,258 Orgenesis Inc. Common Stock shares in Q4 2021, an estimated $260K.
  • HRT Financial first reported a position in Orgenesis Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • HRT Financial's Orgenesis Inc. Common Stock position peaked at $280K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.